Sildenafil may elevate melanoma risk

Dermatologic Therapy

Volumn 27, Issue 5, 2014, Pages 313-

  Grichnik, James M ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PHOSPHODIESTERASE V; SILDENAFIL; PHOSPHODIESTERASE V INHIBITOR; PIPERAZINE DERIVATIVE; SULFONE;

BASAL CELL CARCINOMA; CANCER RISK; DOWN REGULATION; DRUG USE; ERECTILE DYSFUNCTION; FOLLOW UP; HAZARD RATIO; HUMAN; MELANOMA; METASTASIS; NOTE; ONCOGENE N RAS; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; CHEMICALLY INDUCED; MALE; SKIN TUMOR;

ERECTILE DYSFUNCTION; HUMANS; MALE; MELANOMA; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; SKIN NEOPLASMS; SULFONES;

EID: 84907851714     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12162     Document Type: Note

References (1)

1. Li WQ, Qureshi AA, Robinson KC, Han J. Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study. JAMA Intern Med 2014: 174: 964-970.